127 related articles for article (PubMed ID: 9848781)
1. Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition.
Penny MJ; Boyd RA; Hall BM
J Am Soc Nephrol; 1998 Dec; 9(12):2272-82. PubMed ID: 9848781
[TBL] [Abstract][Full Text] [Related]
2. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli.
Penny MJ; Boyd RA; Hall BM
Kidney Int; 1997 Apr; 51(4):1059-68. PubMed ID: 9083271
[TBL] [Abstract][Full Text] [Related]
3. Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis.
Penny MJ; Boyd RA; Hall BM
J Exp Med; 1998 Nov; 188(10):1775-84. PubMed ID: 9815255
[TBL] [Abstract][Full Text] [Related]
4. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells.
Spicer ST; Ha H; Boyd RA; He XY; Carter N; Tran G; Penny MJ; Hodgkinson SJ; Hall BM
J Immunol; 2001 Oct; 167(7):3725-33. PubMed ID: 11564788
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody.
Hasegawa Y; Kaneoka H; Tanaka T; Ogahara S; Matsumae T; Noda R; Yoshitake K; Murata T; Naito S
Nephron; 2001 Jul; 88(3):233-40. PubMed ID: 11423754
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
Wu H; Walters G; Knight JF; Alexander SI
J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
[TBL] [Abstract][Full Text] [Related]
8. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis.
Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E
Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746
[TBL] [Abstract][Full Text] [Related]
9. Heymann nephritis in Lewis rats.
Wang YM; Lee VWS; Wu H; Harris DCH; Alexander SI
Curr Protoc Immunol; 2015 Apr; 109():15.29.1-15.29.6. PubMed ID: 25845564
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
[TBL] [Abstract][Full Text] [Related]
11. Dietary ribonucleotides modulate type 1 and type 2 T-helper cell responses against ovalbumin in young BALB/cJ mice.
Jyonouchi H; Sun S; Winship T; Kuchan MJ
J Nutr; 2001 Apr; 131(4):1165-70. PubMed ID: 11285320
[TBL] [Abstract][Full Text] [Related]
12. Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis.
Nieto E; Escudero E; Navarro E; Yáñez-Mo M; Martín A; Pérez de Lema G; Sánchez-Madrid F; Mampaso F
J Am Soc Nephrol; 2002 Apr; 13(4):937-945. PubMed ID: 11912253
[TBL] [Abstract][Full Text] [Related]
13. The role of T cells in the mediation of glomerular injury in Heymann's nephritis in the rat.
Quiza CG; Leenaerts PL; Hall BM
Int Immunol; 1992 Apr; 4(4):423-32. PubMed ID: 1591215
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy.
Wu CC; Chen JS; Chen SJ; Lin SH; Chen A; Chang LC; Sytwu HK; Lin YF
Kidney Int; 2007 Oct; 72(7):831-40. PubMed ID: 17622271
[TBL] [Abstract][Full Text] [Related]
15. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
17. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.
Blume C; Heise G; Hess A; Waldner C; Grabensee B; Schroer K; Heering P
Nephron Exp Nephrol; 2005; 100(2):e104-12. PubMed ID: 15855806
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of murine lupus nephritis by mycophenolate mofetil.
Van Bruggen MC; Walgreen B; Rijke TP; Berden JH
J Am Soc Nephrol; 1998 Aug; 9(8):1407-15. PubMed ID: 9697662
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide.
Branten AJ; du Buf-Vereijken PW; Vervloet M; Wetzels JF
Am J Kidney Dis; 2007 Aug; 50(2):248-56. PubMed ID: 17660026
[TBL] [Abstract][Full Text] [Related]
20. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A; Mikecz K; Tao P; Glant TT
J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
